Elite in Choroideremia

Robert E. Maclaren

Oxford, ENG, GB 
Elite in Choroideremia
Oxford, ENG, GB 
OverviewLocationsClinical Research

Overview

Robert Maclaren practices in Oxford, United Kingdom. Mr. Maclaren is rated as an Elite expert by MediFind in the treatment of Choroideremia. His top areas of expertise are Choroideremia, X-Linked Retinitis Pigmentosa (XLRP), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 306 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 70 articles and participated in 1 clinical trial in the study of Choroideremia.

Gender
Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Wing, ENG OX39DU, United Kingdom
London, ENG, United Kingdom
Headley Way, Headley, ENG, United Kingdom
Cambridge, ENG CB20QQ, United Kingdom
Moorfields, NIR, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open Label Phase 2 Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)
An Open Label Phase 2 Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)
Enrollment Status: Completed
Publish Date: August 05, 2021
Intervention Type: Genetic
Study Phase: Phase 2
A Prospective Randomised Controlled Trial to Assess Improved Binocular Visual Function in Young Patients Undergoing Monocular Cataract Surgery With a Bifocal Intraocular Lens.
A Prospective Randomised Controlled Trial to Assess Improved Binocular Visual Function in Young Patients Undergoing Monocular Cataract Surgery With a Bifocal Intraocular Lens.
Enrollment Status: Terminated
Publish Date: June 13, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC)
A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC)
Enrollment Status: Completed
Publish Date: October 10, 2017
Intervention Type: Procedure
Study Phase: Phase 4
View 2 Less Clinical Trials

306 Total Publications

Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).
Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).
Journal: Ophthalmic genetics
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maclaren's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile